- Omeros Corporation Reports First Quarter 2024 Financial Results
- Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024
- Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress
- Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
- Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
More ▼
Key statistics
On Friday, Omeros Corp (OMER:NMQ) closed at 3.45, 275.00% above the 52 week low of 0.92 set on Oct 16, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.30 |
---|---|
High | 3.57 |
Low | 3.28 |
Bid | 3.30 |
Offer | 3.43 |
Previous close | 3.31 |
Average volume | 352.64k |
---|---|
Shares outstanding | 57.94m |
Free float | 55.40m |
P/E (TTM) | -- |
Market cap | 217.29m USD |
EPS (TTM) | -2.79 USD |
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼